Adipotide dosage and evidence

What is Adipotide?

How does Adipotide work?

One part of the peptide sticks to prohibitin, a protein on blood vessels in fat. The other part breaks the mitochondria, the power plants, of those vessel cells. That starves the fat of blood.

What do people who took Adipotide report?

This is what real people say happened to them, good and bad. Nobody measured it. A report cannot tell a real effect from the lift people get just from expecting it to work, from a diet or training change made at the same time, or from what was really in the vial. We still put it near the top. It is the next best thing to a study in people: what happens when real people use it, including what goes wrong.

• Discussed mainly as a cautionary example rather than as something people are currently running, and the advice that dominates is to avoid it.
• The specific problem raised is the kidney. An account circulated in these threads of someone whose creatinine rose several fold while using it, into a range the discussion treated as the kidneys failing.
• The more technical posters say the kidney damage comes from the drug doing what it is meant to do, not from bad luck. The contents of the destroyed fat cells all hit the blood at once. The comparison they reach for is tumour lysis.
• A dose gap is noted repeatedly: the amounts used in the primate work people cite are far larger than what is sold in vials, which posters take as evidence that the window between an effect and toxicity is too narrow to work with, and as the likely reason development stopped.
• Weight loss is not generally disputed in these threads. The argument is entirely about whether the cost in kidney function is acceptable, and the position described as consensus is that it is not.

Sources: MESO-Rx threads on adipotide and on fat loss peptides generally, read through site-restricted search results because that board does not serve automated fetches from this environment, September 2026. Nothing above is attributed to any specific post and no post is reproduced.

The evidence, in charts

The studies we cite

• Animal study2011
  A peptidomimetic targeting white fat causes weight loss and improved insulin resistance in obese monkeys

  In obese rhesus monkeys, adipotide killed off blood vessels in white fat. They lost 7.4 to 14.7% of their weight in four weeks and handled insulin better. Kidney changes grew with the dose and went away after stopping.

  Adipotide induced apoptosis in white-fat blood vessels of obese rhesus monkeys, producing 7.4 to 14.7% weight loss in four weeks with improved insulin resistance; renal proximal tubule changes were dose-dependent and reversible.

  PMID 22072637 Science Translational Medicine
• Animal study2004
  Reversal of obesity by targeted ablation of adipose tissue

  In mice, the first study. A short homing piece stuck to prohibitin on the blood vessels of white fat. Joined to a cell-killing peptide, it destroyed fat and reversed obesity.

  Original mouse work: the CKGGRAKDC homing motif binds prohibitin on white-fat vasculature, and coupling it to a proapoptotic peptide ablated fat and reversed obesity.

  PMID 15133506 Nature Medicine